安哥拉罗安达一家社区医院的耐多药结核分枝杆菌

IF 7.2 2区医学 Q1 IMMUNOLOGY

Emerging Infectious Diseases Pub Date : 2025-02-21 DOI:10.3201/eid3103.241831

Ngiambudulu M. Francisco, Alberto Gaviraghi, Francesca Alladio, Ralph Huits, Bruna Carnielli, Elena Salvador, Giacomo Stroffolini, Niccolò Ronzoni, Paolo Cattaneo, Concetta Castilletti, Alberto Kalume, Cristina Mazzi, Alberto Matteelli, Dora Buonfrate, Federico G. Gobbi

{"title":"安哥拉罗安达一家社区医院的耐多药结核分枝杆菌","authors":"Ngiambudulu M. Francisco, Alberto Gaviraghi, Francesca Alladio, Ralph Huits, Bruna Carnielli, Elena Salvador, Giacomo Stroffolini, Niccolò Ronzoni, Paolo Cattaneo, Concetta Castilletti, Alberto Kalume, Cristina Mazzi, Alberto Matteelli, Dora Buonfrate, Federico G. Gobbi","doi":"10.3201/eid3103.241831","DOIUrl":null,"url":null,"abstract":"<p>In a longitudinal study in a first-level hospital in Luanda, Angola, we found rifampin-resistant and multidrug-resistant tuberculosis (TB) in 38 (8%, 95% CI 5.7–10.8) of 474 patients with no previous history of TB. Of note, 2 patients (0.4%, 95% CI 0.1–1.5) demonstrated pre–extensively drug-resistant TB.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":"3 1","pages":""},"PeriodicalIF":7.2000,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, Angola\",\"authors\":\"Ngiambudulu M. Francisco, Alberto Gaviraghi, Francesca Alladio, Ralph Huits, Bruna Carnielli, Elena Salvador, Giacomo Stroffolini, Niccolò Ronzoni, Paolo Cattaneo, Concetta Castilletti, Alberto Kalume, Cristina Mazzi, Alberto Matteelli, Dora Buonfrate, Federico G. Gobbi\",\"doi\":\"10.3201/eid3103.241831\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>In a longitudinal study in a first-level hospital in Luanda, Angola, we found rifampin-resistant and multidrug-resistant tuberculosis (TB) in 38 (8%, 95% CI 5.7–10.8) of 474 patients with no previous history of TB. Of note, 2 patients (0.4%, 95% CI 0.1–1.5) demonstrated pre–extensively drug-resistant TB.</p>\",\"PeriodicalId\":11595,\"journal\":{\"name\":\"Emerging Infectious Diseases\",\"volume\":\"3 1\",\"pages\":\"\"},\"PeriodicalIF\":7.2000,\"publicationDate\":\"2025-02-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Emerging Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3201/eid3103.241831\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3201/eid3103.241831","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

在安哥拉罗安达一家一级医院进行的一项纵向研究中，我们在474名无结核病史的患者中发现38例（8%,95% CI 5.7-10.8）出现利福平耐药和耐多药结核病（TB）。值得注意的是，2名患者（0.4%,95% CI 0.1-1.5）表现出广泛耐药前结核病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, Angola

In a longitudinal study in a first-level hospital in Luanda, Angola, we found rifampin-resistant and multidrug-resistant tuberculosis (TB) in 38 (8%, 95% CI 5.7–10.8) of 474 patients with no previous history of TB. Of note, 2 patients (0.4%, 95% CI 0.1–1.5) demonstrated pre–extensively drug-resistant TB.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Emerging Infectious Diseases 医学-传染病学

CiteScore

17.30

自引率

1.70%

发文量

505

审稿时长

1 months

期刊介绍： Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.